These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6112718)

  • 1. [The response of pancreatic alpha and beta cells to oral glucose stimulation in subjects with risk of diabetes].
    Ferrero E; Casale G; Ravecca D; Ricci C
    Minerva Med; 1981 Apr; 72(17):1065-70. PubMed ID: 6112718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic alpha-cell function in idiopathic reactive hypoglycemia.
    Ahmadpour S; Kabadi UM
    Metabolism; 1997 Jun; 46(6):639-43. PubMed ID: 9186298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon and insulin secretion in potential diabetes.
    Tiengo A; Fedele D; Muggeo M; Nosadini R; Molinari M; Garotti MC; Crepaldi G
    Acta Diabetol Lat; 1978; 15(3-4):143-51. PubMed ID: 360748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose and ATP levels in pancreatic islet tissue of normal and diabetic rats.
    Matschinsky FM; Pagliara AS; Stillings SN; Hover BA
    J Clin Invest; 1976 Nov; 58(5):1193-200. PubMed ID: 136453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptozotocin diabetes in the monkey: plasma levels of glucose, insulin, glucagon, and somatostatin, with corresponding morphometric analysis of islet endocrine cells.
    Jones CW; Reynolds WA; Hoganson GE
    Diabetes; 1980 Jul; 29(7):536-46. PubMed ID: 6103856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cysteamine and antibody to somatostatin on islet cell function in vitro. Evidence that intracellular somatostatin deficiency augments insulin and glucagon secretion.
    Patel YC; Pierzchala I; Amherdt M; Orci L
    J Clin Invest; 1985 Apr; 75(4):1249-55. PubMed ID: 2859301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The historic role of insulin in the physiopathology of the metabolic complications from pancreatic diabetes. Therapeutic implications for somatostatin].
    Guillemin R; Fontaine M
    C R Acad Hebd Seances Acad Sci D; 1975 May; 280(20):2353-6. PubMed ID: 807423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin, glucagon, and insulin secretion from perfused pancreas of BB rats.
    Ruggere MD; Patel YC
    Am J Physiol; 1984 Aug; 247(2 Pt 1):E221-7. PubMed ID: 6147095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cholinergic regulation of insulin and glucagon secretion in healthy people and in patients with non-insulin dependent diabetes].
    Czyźyk A; Lawecki J; Strycek-Kaminska D
    Z Gesamte Inn Med; 1981 Jan; 36(2):43-7. PubMed ID: 7013296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tolbutamide on insulin, glucagon, and somatostatin release from the diabetic rat pancreas with special reference to glucose concentration.
    Kadowaki S; Taminato T; Chiba T; Nozawa M; Fujita T; Norman AW
    Endocrinology; 1983 Jun; 112(6):2187-92. PubMed ID: 6133743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normalization of the paradoxic secretion of glucagon in diabetics who were controlled by the artificial beta cell.
    Shichiri M; Kawamori R; Abe H
    Diabetes; 1979 Apr; 28(4):272-5. PubMed ID: 374171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbohydrate metabolism and pancreatic islet-cell function in thalassemia major.
    Costin G; Kogut MD; Hyman C; Ortega JA
    Diabetes; 1977 Mar; 26(3):230-40. PubMed ID: 320076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance.
    Mitrakou A; Kelley D; Mokan M; Veneman T; Pangburn T; Reilly J; Gerich J
    N Engl J Med; 1992 Jan; 326(1):22-9. PubMed ID: 1727062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal pancreatic alpha-cell function in first-degree relatives of known diabetics.
    Kirk RD; Dunn P; Smith JR; Beaven DW; Donald RA
    J Clin Endocrinol Metab; 1975 May; 40(5):913-6. PubMed ID: 1092713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal secretion of insulin and glucagon by the in vitro perfused pancreas of the genetically diabetic Chinese hamster.
    Frankel BJ; Gerich JE; Hagura R; Fanska RE; Gerritsen GC; Grodsky GM
    J Clin Invest; 1974 Jun; 53(6):1637-46. PubMed ID: 4830228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of pancreatic glucagon secretion during a continuous glucose infusion in early and overt diabetics.
    Schulz B; Ziegler M; Witt S; Rjasanowski I; Heinke P; Bibergeil H
    Acta Endocrinol (Copenh); 1978 Oct; 89(2):329-38. PubMed ID: 696182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon suppression improves glucoregulation in moderate but not chronic severe diabetes.
    Lickley HL; Kemmer FW; Doi K; Vranic M
    Am J Physiol; 1983 Oct; 245(4):E424-9. PubMed ID: 6137957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic alpha cell response to alanine during and after normal and diabetic pregnancies.
    Kitzmiller JL; Tanenberg RJ; Aoki TT; Tabatabaii A; Gleason R; Jewett JF; Hare JW; Soeldner JS
    Obstet Gynecol; 1980 Oct; 56(4):440-5. PubMed ID: 6999401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance.
    Alvestrand A; Mujagic M; Wajngot A; Efendic S
    Clin Nephrol; 1989 Apr; 31(4):175-83. PubMed ID: 2565775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.